[
    [
        {
            "time": "",
            "orginal_text": "7家药企上榜胡润中国百强健康民营企业",
            "features": {
                "keywords": [
                    "药企",
                    "胡润",
                    "百强",
                    "健康",
                    "民营企业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "7家药企上榜胡润中国百强健康民营企业",
            "scores": {
                "News_content": "7家药企上榜胡润中国百强健康民营企业",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "泰格医药拟赴港上市 CRO行业再迎A+H 新军",
            "features": {
                "keywords": [
                    "泰格医药",
                    "赴港上市",
                    "CRO",
                    "A+H"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "泰格医药拟赴港上市 CRO行业再迎A+H 新军",
            "scores": {
                "News_content": "泰格医药拟赴港上市 CRO行业再迎A+H 新军",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药板块强势反弹！这些上市公司迎“出海”机遇",
            "features": {
                "keywords": [
                    "医药板块",
                    "反弹",
                    "出海",
                    "机遇"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药板块强势反弹！这些上市公司迎“出海”机遇",
            "scores": {
                "News_content": "医药板块强势反弹！这些上市公司迎“出海”机遇",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "外资撤离A股！机构：不宜过度悲观",
            "features": {
                "keywords": [
                    "外资",
                    "撤离",
                    "A股",
                    "悲观"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场情绪"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "外资撤离A股！机构：不宜过度悲观",
            "scores": {
                "News_content": "外资撤离A股！机构：不宜过度悲观",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "中国百强健康民营企业揭榜：恒瑞医药价值第一 迈瑞医疗第二",
            "features": {
                "keywords": [
                    "百强",
                    "健康",
                    "民营企业",
                    "恒瑞医药",
                    "迈瑞医疗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "中国百强健康民营企业揭榜：恒瑞医药价值第一 迈瑞医疗第二",
            "scores": {
                "News_content": "中国百强健康民营企业揭榜：恒瑞医药价值第一 迈瑞医疗第二",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "胡润发布《2020胡润中国百强健康民营企业》",
            "features": {
                "keywords": [
                    "胡润",
                    "百强",
                    "健康",
                    "民营企业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "健康"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "胡润发布《2020胡润中国百强健康民营企业》",
            "scores": {
                "News_content": "胡润发布《2020胡润中国百强健康民营企业》",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "今日COVID-19研发动态 | 再生元、康希诺生物取得新进展",
            "features": {
                "keywords": [
                    "COVID-19",
                    "研发",
                    "再生元",
                    "康希诺生物",
                    "进展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "今日COVID-19研发动态 | 再生元、康希诺生物取得新进展",
            "scores": {
                "News_content": "今日COVID-19研发动态 | 再生元、康希诺生物取得新进展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]